Phenotypic analysis of dengue virus isolates associated with dengue fever and dengue hemorrhagic fever for cellular attachment, replication and interferon signaling ability

Virus Research

Volumn 145, Issue 1, 2009, Pages 31-38

  Takhampunya, Ratree ^a,b   Palmer, Dupeh R ^a   McClain, Sasha ^a   Barvir, David A ^a   Lynch, Julia ^a   Jarman, Richard G ^b   Thomas, Stephen ^b   Gibbons, Robert V ^b   Burgess, Timothy H ^c   Sun, Peifang ^c   Kamau, Edwin ^a   Putnak, Robert ^a   Zhang, Chunlin ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^c NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

Dengue viruses; DF; DHF; Interferon; Replication

Indexed keywords

ALPHA INTERFERON; STAT1 PROTEIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DENGUE; DENGUE VIRUS; FEMALE; HUMAN; HUMAN CELL; INFANT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; THAILAND; VIRAL GENETICS; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION;

ADOLESCENT; CELL LINE; CHILD; CHILD, PRESCHOOL; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFANT; INTERFERON-ALPHA; MALE; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; THAILAND; VIRUS ATTACHMENT; VIRUS REPLICATION;

DENGUE VIRUS; DENGUE VIRUS GROUP;

EID: 69449085327     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.05.016     Document Type: Article

References (40)

1. Alen M.M., Kaptein S.J., De Burghgraeve T., Balzarini J., Neyts J., and Schols D. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection. Virology 387 (2009) 67-75
2. Bennett S.N., Holmes E.C., Chirivella M., Rodriguez D.M., Beltran M., Vorndam V., Gubler D.J., and McMillan W.O. Molecular evolution of dengue 2 virus in Puerto Rico: positive selection in the viral envelope accompanies clade reintroduction. J. Gen. Virol. 87 Pt 4 (2006) 885-893
3. Co J.K., Verma S., Gurjav U., Sumibcay L., and Nerurkar V.R. Interferon-alpha and -beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy. J. Infect. Dis. 196 5 (2007) 712-718
4. Cummings D.A., Irizarry R.A., Huang N.E., Endy T.P., Nisalak A., Ungchusak K., and Burke D.S. Travelling waves in the occurrence of dengue haemorrhagic fever in Thailand. Nature 427 6972 (2004) 344-347
5. Halstead S.B. Pathogenesis of dengue: challenges to molecular biology. Science 239 4839 (1988) 476-481
6. Halstead S.B., Nimmannitya S., and Cohen S.N. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J. Biol. Med. 42 5 (1970) 311-328
7. Halstead S.B., and Simasthien P. Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host. Yale J. Biol. Med. 42 5 (1970) 276-292
8. Heim M.H., Moradpour D., and Blum H.E. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J. Virol. 73 10 (1999) 8469-8475
9. Ho L.J., Hung L.F., Weng C.Y., Wu W.L., Chou P., Lin Y.L., Chang D.M., Tai T.Y., and Lai J.H. Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J. Immunol. 174 12 (2005) 8163-8172
10. Jones M., Davidson A., Hibbert L., Gruenwald P., Schlaak J., Ball S., Foster G.R., and Jacobs M. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J. Virol. 79 9 (2005) 5414-5420
11. Kliks S.C., Nisalak A., Brandt W.E., Wahl L., and Burke D.S. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40 4 (1989) 444-451
12. Klungthong C., Zhang C., Mammen Jr. M.P., Ubol S., and Holmes E.C. The molecular epidemiology of dengue virus serotype 4 in Bangkok, Thailand. Virology 329 1 (2004) 168-179
13. Lei H.Y., Yeh T.M., Liu H.S., Lin Y.S., Chen S.H., and Liu C.C. Immunopathogenesis of dengue virus infection. J. Biomed. Sci. 8 5 (2001) 377-388
14. Leitmeyer K.C., Vaughn D.W., Watts D.M., Salas R., Villalobos I., de C., Ramos C., and Rico-Hesse R. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73 6 (1999) 4738-4747
15. Libraty D.H., Endy T.P., Houng H.S., Green S., Kalayanarooj S., Suntayakorn S., Chansiriwongs W., Vaughn D.W., Nisalak A., Ennis F.A., and Rothman A.L. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J. Infect. Dis. 185 9 (2002) 1213-1221
16. Lozach P.Y., Burleigh L., Staropoli I., Navarro-Sanchez E., Harriague J., Virelizier J.L., Rey F.A., Despres P., Arenzana-Seisdedos F., and Amara A. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J. Biol. Chem. 280 25 (2005) 23698-23708
17. Mangada M.N., and Igarashi A. Sequences of terminal non-coding regions from four dengue-2 viruses isolated from patients exhibiting different disease severities. Virus Genes 14 1 (1997) 5-12
18. Marijke M.F., Alen S.J.F.K., Tine De B., Jan B., Johan N., and Dominique S. Antiviral activity of carbohydrate-binding agents and role of DC-SIGN in dengue virus infection. Virology 387 (2009) 67-75
19. Muller U., Steinhoff U., Reis L.F., Hemmi S., Pavlovic J., Zinkernagel R.M., and Aguet M. Functional role of type I and type II interferons in antiviral defense. Science 264 5167 (1994) 1918-1921
20. Munoz-Jordan J.L., Laurent-Rolle M., Ashour J., Martinez-Sobrido L., Ashok M., Lipkin W.I., and Garcia-Sastre A. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J. Virol. 79 13 (2005) 8004-8013
21. Munoz-Jordan J.L., Sanchez-Burgos G.G., Laurent-Rolle M., and Garcia-Sastre A. Inhibition of interferon signaling by dengue virus. Proc. Natl. Acad. Sci. USA 100 24 (2003) 14333-14338
22. Navarro-Sanchez E., Altmeyer R., Amara A., Schwartz O., Fieschi F., Virelizier J.L., Arenzana-Seisdedos F., and Despres P. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep. 4 7 (2003) 723-728
23. Navarro-Sanchez E., Despres P., and Cedillo-Barron L. Innate immune responses to dengue virus. Arch. Med. Res. 36 5 (2005) 425-435
24. Nisalak A., Endy T.P., Nimmannitya S., Kalayanarooj S., Thisayakorn U., Scott R.M., Burke D.S., Hoke C.H., Innis B.L., and Vaughn D.W. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am. J. Trop. Med. Hyg. 68 2 (2003) 191-202
25. Palmer D.R., Fernandez S., Bisbing J., Peachman K.K., Rao M., Barvir D., Gunther V., Burgess T., Kohno Y., Padmanabhan R., and Sun W. Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells. J. Gen. Virol. 88 Pt 1 (2007) 148-156
26. Palmer D.R., Sun P., Celluzzi C., Bisbing J., Pang S., Sun W., Marovich M.A., and Burgess T. Differential effects of dengue virus on infected and bystander dendritic cells. J. Virol. 79 4 (2005) 2432-2439
27. Pandey B.D., and Igarashi A. Severity-related molecular differences among nineteen strains of dengue type 2 viruses. Microbiol. Immunol. 44 3 (2000) 179-188
28. Rico-Hesse R., Harrison L.M., Salas R.A., Tovar D., Nisalak A., Ramos C., Boshell J., de Mesa M.T., Nogueira R.M., and da Rosa A.T. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230 2 (1997) 244-251
29. Rosen L. Pathogenesis of hemorrhagic dengue: critical discussion of current hypotheses. Bull. Soc. Pathol. Exot. Filiales 79 3 (1986) 342-349
30. Sadon N., Delers A., Jarman R.G., Klungthong C., Nisalak A., Gibbons R.V., and Vassilev V. A new quantitative RT-PCR method for sensitive detection of dengue virus in serum samples. J. Virol. Methods 153 1 (2008) 1-6
31. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14 4 (2001) 778-809 table of contents
32. Sanchez V., Hessler C., DeMonfort A., Lang J., and Guy B. Comparison by flow cytometry of immune changes induced in human monocyte-derived dendritic cells upon infection with dengue 2 live-attenuated vaccine or 16681 parental strain. FEMS Immunol Med Microbiol. 46 (2006) 113-123
33. Sun P., Celluzzi C.M., Marovich M., Subramanian H., Eller M., Widjaja S., Palmer D., Porter K., Sun W., and Burgess T. CD40 ligand enhances dengue viral infection of dendritic cellsa: a possible mechanism for T cell-mediated immunopathology. J. Immunol. 177 9 (2006) 6497-6503
34. Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., Trumpfheller C., Finke J., Sun W., Eller M.A., Pattanapanyasat K., Sarasombath S., Birx D.L., Steinman R.M., Schlesinger S., and Marovich M.A. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197 7 (2003) 823-829
35. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., Endy T.P., Raengsakulrach B., Rothman A.L., Ennis F.A., and Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181 1 (2000) 2-9
36. Wang S., He R., and Anderson R. PrM- and cell-binding domains of the dengue virus E protein. J. Virol. 73 3 (1999) 2547-2551
37. Wu M., Xu Y., Lin S., Zhang X., Xiang L., and Yuan Z. Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1. J. Gen. Virol. 88 Pt 12 (2007) 3260-3269
38. Wu S.J., Grouard-Vogel G., Sun W., Mascola J.R., Brachtel E., Putvatana R., Louder M.K., Filgueira L., Marovich M.A., Wong H.K., Blauvelt A., Murphy G.S., Robb M.L., Innes B.L., Birx D.L., Hayes C.G., and Frankel S.S. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6 7 (2000) 816-820
39. Zhang C., Mammen Jr. M.P., Chinnawirotpisan P., Klungthong C., Rodpradit P., Monkongdee P., Nimmannitya S., Kalayanarooj S., and Holmes E.C. Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence. J. Virol 79 24 (2005) 15123-15130
40. Zhang C., Mammen Jr. M.P., Chinnawirotpisan P., Klungthong C., Rodpradit P., Nisalak A., Vaughn D.W., Nimmannitya S., Kalayanarooj S., and Holmes E.C. Structure and age of genetic diversity of dengue virus type 2 in Thailand. J. Gen. Virol. 87 Pt 4 (2006) 873-883